vs
AMERICAN SHARED HOSPITAL SERVICES（AMS）与Natera, Inc.（NTRA）财务数据对比。点击上方公司名可切换其他公司
Natera, Inc.的季度营收约是AMERICAN SHARED HOSPITAL SERVICES的86.1倍（$665.5M vs $7.7M）。Natera, Inc.净利率更高（7.1% vs -8.2%，领先15.3%）。Natera, Inc.同比增速更快（39.8% vs -14.8%）。Natera, Inc.自由现金流更多（$37.8M vs $-2.7M）。过去两年Natera, Inc.的营收复合增速更高（34.5% vs 21.7%）
美国共享医院服务公司为医疗机构提供放射治疗、立体定向放射外科及诊断成像设备的整体外包解决方案，免除医院高昂的前期资本投入，主要业务覆盖北美，同时服务拉美及部分亚太地区的公立、私立医院客户。
Natera是总部位于美国得克萨斯州奥斯汀的临床基因检测企业，主打无创游离DNA（cfDNA）检测技术，业务覆盖女性健康、肿瘤及器官健康三大核心赛道。其自研专利技术结合前沿分子生物学手段与生物信息学工具矩阵，可实现单管血液样本中低至单个分子级别的高灵敏度检测。
AMS vs NTRA — 直观对比
营收规模更大
NTRA
是对方的86.1倍
$7.7M
营收增速更快
NTRA
高出54.6%
-14.8%
净利率更高
NTRA
高出15.3%
-8.2%
自由现金流更多
NTRA
多$40.5M
$-2.7M
两年增速更快
NTRA
近两年复合增速
21.7%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $7.7M | $665.5M |
| 净利润 | $-631.0K | $47.3M |
| 毛利率 | 11.7% | — |
| 营业利润率 | -18.1% | -3.4% |
| 净利率 | -8.2% | 7.1% |
| 营收同比 | -14.8% | 39.8% |
| 净利润同比 | 52.5% | 187.9% |
| 每股收益（稀释后） | $-0.09 | $0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMSNTRA
| Q4 25 | $7.7M | $665.5M | ||
| Q3 25 | $7.2M | $592.2M | ||
| Q2 25 | $7.1M | $546.6M | ||
| Q1 25 | $6.1M | $501.8M | ||
| Q4 24 | $9.1M | $476.1M | ||
| Q3 24 | $7.0M | $439.8M | ||
| Q2 24 | $7.1M | $413.4M | ||
| Q1 24 | $5.2M | $367.7M |
净利润AMSNTRA
| Q4 25 | $-631.0K | $47.3M | ||
| Q3 25 | $-17.0K | $-87.5M | ||
| Q2 25 | $-280.0K | $-100.9M | ||
| Q1 25 | $-625.0K | $-66.9M | ||
| Q4 24 | $-1.3M | $-53.8M | ||
| Q3 24 | $-207.0K | $-31.6M | ||
| Q2 24 | $3.6M | $-37.5M | ||
| Q1 24 | $119.0K | $-67.6M |
毛利率AMSNTRA
| Q4 25 | 11.7% | — | ||
| Q3 25 | 22.1% | — | ||
| Q2 25 | 23.1% | — | ||
| Q1 25 | 15.4% | — | ||
| Q4 24 | 35.3% | — | ||
| Q3 24 | 19.6% | — | ||
| Q2 24 | 35.0% | — | ||
| Q1 24 | 41.1% | — |
营业利润率AMSNTRA
| Q4 25 | -18.1% | -3.4% | ||
| Q3 25 | -4.8% | -16.5% | ||
| Q2 25 | -7.7% | -20.2% | ||
| Q1 25 | -21.3% | -15.8% | ||
| Q4 24 | -20.2% | -13.6% | ||
| Q3 24 | -12.7% | -8.9% | ||
| Q2 24 | -0.0% | -10.6% | ||
| Q1 24 | -1.6% | -20.2% |
净利率AMSNTRA
| Q4 25 | -8.2% | 7.1% | ||
| Q3 25 | -0.2% | -14.8% | ||
| Q2 25 | -4.0% | -18.5% | ||
| Q1 25 | -10.2% | -13.3% | ||
| Q4 24 | -14.6% | -11.3% | ||
| Q3 24 | -3.0% | -7.2% | ||
| Q2 24 | 51.0% | -9.1% | ||
| Q1 24 | 2.3% | -18.4% |
每股收益（稀释后）AMSNTRA
| Q4 25 | $-0.09 | $0.36 | ||
| Q3 25 | $0.00 | $-0.64 | ||
| Q2 25 | $-0.04 | $-0.74 | ||
| Q1 25 | $-0.10 | $-0.50 | ||
| Q4 24 | $-0.21 | $-0.41 | ||
| Q3 24 | $-0.03 | $-0.26 | ||
| Q2 24 | $0.55 | $-0.30 | ||
| Q1 24 | $0.02 | $-0.56 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.5M | — |
| 总债务越低越好 | $17.4M | — |
| 股东权益账面价值 | $24.0M | $1.7B |
| 总资产 | $55.5M | $2.4B |
| 负债/权益比越低杠杆越低 | 0.72× | — |
8季度趋势，按日历期对齐
现金及短期投资AMSNTRA
| Q4 25 | $3.5M | — | ||
| Q3 25 | $5.1M | $1.0M | ||
| Q2 25 | $11.1M | $16.0M | ||
| Q1 25 | $11.2M | $17.8M | ||
| Q4 24 | $11.0M | $22.7M | ||
| Q3 24 | $13.8M | $29.5M | ||
| Q2 24 | $14.2M | $90.3M | ||
| Q1 24 | $12.8M | $69.1M |
总债务AMSNTRA
| Q4 25 | $17.4M | — | ||
| Q3 25 | $18.2M | — | ||
| Q2 25 | $19.1M | — | ||
| Q1 25 | $19.9M | — | ||
| Q4 24 | $20.4M | — | ||
| Q3 24 | $14.4M | — | ||
| Q2 24 | $15.1M | — | ||
| Q1 24 | $15.6M | — |
股东权益AMSNTRA
| Q4 25 | $24.0M | $1.7B | ||
| Q3 25 | $24.6M | $1.3B | ||
| Q2 25 | $24.5M | $1.2B | ||
| Q1 25 | $24.6M | $1.2B | ||
| Q4 24 | $25.2M | $1.2B | ||
| Q3 24 | $26.4M | $878.5M | ||
| Q2 24 | $26.5M | $836.5M | ||
| Q1 24 | $22.8M | $794.1M |
总资产AMSNTRA
| Q4 25 | $55.5M | $2.4B | ||
| Q3 25 | $59.6M | $1.8B | ||
| Q2 25 | $63.5M | $1.8B | ||
| Q1 25 | $63.3M | $1.7B | ||
| Q4 24 | $60.2M | $1.7B | ||
| Q3 24 | $63.3M | $1.6B | ||
| Q2 24 | $60.8M | $1.5B | ||
| Q1 24 | $50.1M | $1.5B |
负债/权益比AMSNTRA
| Q4 25 | 0.72× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.78× | — | ||
| Q1 25 | 0.81× | — | ||
| Q4 24 | 0.81× | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | 0.57× | — | ||
| Q1 24 | 0.68× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-704.0K | $73.9M |
| 自由现金流经营现金流 - 资本支出 | $-2.7M | $37.8M |
| 自由现金流率自由现金流/营收 | -34.8% | 5.7% |
| 资本支出强度资本支出/营收 | 25.7% | 5.4% |
| 现金转化率经营现金流/净利润 | — | 1.56× |
| 过去12个月自由现金流最近4个季度 | $-8.5M | $109.1M |
8季度趋势，按日历期对齐
经营现金流AMSNTRA
| Q4 25 | $-704.0K | $73.9M | ||
| Q3 25 | $1.7M | $59.4M | ||
| Q2 25 | $-372.0K | $37.6M | ||
| Q1 25 | $2.5M | $44.5M | ||
| Q4 24 | $274.0K | $52.9M | ||
| Q3 24 | $472.0K | $51.8M | ||
| Q2 24 | $1.3M | $4.0M | ||
| Q1 24 | $-1.9M | $27.0M |
自由现金流AMSNTRA
| Q4 25 | $-2.7M | $37.8M | ||
| Q3 25 | $-2.0M | $37.0M | ||
| Q2 25 | $-2.3M | $11.7M | ||
| Q1 25 | $-1.5M | $22.6M | ||
| Q4 24 | $-4.4M | $34.8M | ||
| Q3 24 | $-407.0K | $35.5M | ||
| Q2 24 | $70.0K | $-7.7M | ||
| Q1 24 | $-3.0M | $6.7M |
自由现金流率AMSNTRA
| Q4 25 | -34.8% | 5.7% | ||
| Q3 25 | -28.3% | 6.2% | ||
| Q2 25 | -32.1% | 2.1% | ||
| Q1 25 | -24.7% | 4.5% | ||
| Q4 24 | -48.4% | 7.3% | ||
| Q3 24 | -5.8% | 8.1% | ||
| Q2 24 | 1.0% | -1.9% | ||
| Q1 24 | -58.4% | 1.8% |
资本支出强度AMSNTRA
| Q4 25 | 25.7% | 5.4% | ||
| Q3 25 | 51.6% | 3.8% | ||
| Q2 25 | 26.9% | 4.7% | ||
| Q1 25 | 65.7% | 4.3% | ||
| Q4 24 | 51.4% | 3.8% | ||
| Q3 24 | 12.6% | 3.7% | ||
| Q2 24 | 17.2% | 2.8% | ||
| Q1 24 | 22.7% | 5.5% |
现金转化率AMSNTRA
| Q4 25 | — | 1.56× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.36× | — | ||
| Q1 24 | -15.67× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMS
| Direct Patient Services | $4.0M | 51% |
| Rental Income From Medical Services | $2.7M | 35% |
| Pbrt Services | $1.2M | 15% |
NTRA
暂无分部数据
